Related content

Temozolomide treatment for newly diagnosed anaplastic oligodendrogliomas: a clinical efficacy trial

By Taliansky-Aronov A   Bokstein F   Lavon I   Siegal T  

Journal of Neuro-Oncology, Vol. 79, Iss. 2, 2006-09 ,pp. : 153-157

Springer Publishing Company

Access to resources Recommend Favorite

POINT–COUNTERPOINT: What is the optimal trial design to test hyperthermia for carcinoma of the cervix? POINT: Addition of hyperthermia or cisplatin to radiotherapy for patients with cervical cancer; two promising combinations—no definite conclusions

By Van Der Zee J.   Koper P. C. M.   Lutgens L. C. H. W.   Burger C. W.  

International Journal of Hyperthermia, Vol. 18, Iss. 1, 2002-01 ,pp. : 19-24

Informa Healthcare

Access to resources Recommend Favorite

Factors affecting prognosis of patients with intracranial anaplastic oligodendrogliomas: a single institutional review of 70 patients

By Yang Liu-song   Huang Feng-ping   Zheng Kang   Zhang Hai-shi   Zhou Xiang   Bao Xu-hui   Zheng Jia-jun   Chang Chuan   Zhou Liang-fu  

Journal of Neuro-Oncology, Vol. 100, Iss. 1, 2010-10 ,pp. : 113-120

Springer Publishing Company

Access to resources Recommend Favorite

Chemoprevention of colorectal cancer: two steps forward, one step back?

By E Half Elizabeth   Arber Nadir  

Future Oncology, Vol. 2, Iss. 6, 2006-12 ,pp. : 697-704

Future Medicine

Access to resources Recommend Favorite

Proposal of a scoring scale as a survival predictor in intracranial oligodendrogliomas

By Hamlat Abderrahmane   Saikali Stephan   Chaperon Jacques   Carsin-Nicol Beatrice   Calve Michéle   Lesimple Thierry   Ben-hassel Mohamed   Guegan Yvon  

Journal of Neuro-Oncology, Vol. 79, Iss. 2, 2006-09 ,pp. : 159-168

Springer Publishing Company

Access to resources Recommend Favorite